CAVi (Cardiac Amyloidosis Virtual Clinic) is an application exclusively designed for Health Care Practitioners (HCPs) to engage in discussions regarding Cardiac Amyloidosis cases with international practice leaders and peers. This ensures improved health outcomes for patients and facilitates a valuable knowledge exchange among peers. The application serves as a complement to the website, providing a secure environment with an intuitive design. Within this platform, de-identified patient information can be shared along with multimedia attachments, and a panel of experts is available to assist HCPs with their insights.
CAVi is sponsored by Pfizer and developed by IQVIA.